23893-13-2
Chemical Structure
Anhydroerythromycin A
- CAS No.: 23893-13-2
- Formula:C37H65NO12
- Molecular Weight:715.91
IUPAC Name: (1S,2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-ethyl-3-hydroxy-9-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,4,8,10,12,14-hexamethyl-6,15,16-trioxatricyclo[10.2.1.11,4]hexadecan-7-one
InChIKey: YKAVHPRGGAUFDN-JTQLBUQXSA-N
SMILES: C[C@H]([C@H]1O)[C@@](O[C@@]1([C@H](OC2=O)CC)C)([C@@H](C3)C)O[C@]3([C@@H]([C@H]([C@@H]([C@H]2C)O[C@H](O[C@H]4C)C[C@](C)([C@H]4O)OC)C)O[C@H](O[C@@H]5C)[C@@H]([C@H](C5)N(C)C)O)C
Biological Activity: Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed via degradation of erythromycin in acidic aqueous solutions in vitro as well as in vivo. Anhydroerythromycin A is active against S. aureus and B. cereus in vitro (MICs = 12.5 and 6.25 μg/ml, respectively). Anhydroerythromycin A also inhibits steroid 6β-hydroxylase activity associated with the cytochrome P450 (CYP) isoform CYP3A in human liver microsomes.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Anhydroerythromycin A | Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed via degradation of erythromycin in acidic aqueous solutions in vitro as well as in vivo. Anhydroerythromycin A is active against S. aureus and B. cereus in vitro (MICs = 12.5 and 6.25 μg/ml, respectively). Anhydroerythromycin A also inhibits steroid 6β-hydroxylase activity associated with the cytochrome P450 (CYP) isoform CYP3A in human liver microsomes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
